Micropore closure kinetics are delayed following microneedle insertion in elderly subjects

Megan N Kelchen1, Kyle J Siefers1, Courtney C Converse1

  • 1University of Iowa College of Pharmacy, Department of Pharmaceutical Sciences and Experimental Therapeutics, 115 S. Grand Ave, Iowa City, IA 52242, USA.

Insights

Aging skin heals slower after microneedle (MN) insertion, delaying skin barrier restoration. This suggests longer drug delivery windows are possible for elderly individuals using MN technology.

Area of Science:

  • Dermatology
  • Biomedical Engineering
  • Pharmaceutics

Background:

  • Transdermal drug delivery offers advantages, especially for the elderly.
  • Microneedles (MNs) create transient skin micropores for drug delivery, bypassing the skin's barrier function.
  • The effect of aging skin on MN response remains largely unexplored.

Purpose of the Study:

  • To investigate the response of aging skin to microneedle (MN) insertion.
  • To determine if skin barrier restoration differs between young and elderly subjects after MN treatment.
  • To assess the impact of MN parameters (length, number, occlusion) on aged skin healing.

Main Methods:

  • A pilot study comparing young (25.6±2.8 years) and elderly (77.3±6.8 years) subjects.
  • Microneedle arrays of 500μm or 750μm length with 10 or 50 MNs were used.
  • Skin impedance measurements were taken at baseline, post-insertion, and over time under occluded and non-occluded conditions.

Main Results:

  • Skin barrier restoration was significantly slower in elderly subjects compared to controls.
  • Micropore closure time was dependent on MN length, number, and occlusion.
  • Calculated total permeable area and micropore half-life confirmed delayed healing in aged skin.

Conclusions:

  • Aged skin requires longer periods for barrier function restoration after MN insertion.
  • The findings suggest potential for extended drug delivery windows with MNs in the elderly population.
  • This study highlights the need to consider skin aging in MN-based transdermal delivery strategies.